secwatch.observer — SEC 8-K summary
======================================

Issuer:     Assertio Holdings, Inc. (ASRT)
CIK:        0001808665
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001808665-24-000033
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assertio Q2 net product sales $30.7M, GAAP net loss $3.7M; reiterates FY guidance
--------------------------------------------------------------------------------

- Net product sales $30.7M vs $40.1M in Q2 2023; GAAP net loss $0.04/share vs income $0.13/share.
- Rolvedon net sales $15.1M, up from $14.5M QoQ; Indocin $6.9M, down from $8.7M due to generic competition.
- Adjusted EBITDA $5.0M vs $24.8M in Q2 2023; cash from operations $7.4M.
- Cash & short-term investments $88.4M, up from $80.7M; debt $40.0M in 6.5% convertible notes due 2027.
- FY 2024 guidance reaffirmed: net product sales $110-125M, adjusted EBITDA $20-30M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808665/000180866524000033/0001808665-24-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808665/000180866524000033/asrt-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001808665-24-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer